UK IPO fee rises for patents, trade marks and designs from 1 April 2026
UK IPO to raise patent, trade mark and design fees by 25% from 1 April 2026. Early renewals in some cases can secure current rates. Portfolio planning
Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
UK IPO to raise patent, trade mark and design fees by 25% from 1 April 2026. Early renewals in some cases can secure current rates. Portfolio planning
Dr Isabel Blanco in our Spanish trade marks team has been appointed as a Partner of Boult Wade Tennant Spain, S.L.P.
Partner Susi Fish is attending the 9th annual IPOwners Spring Summit in Washington, DC, USA on 18 March.
Boult’s trade mark team has been nominated for Trademark Prosecution (Patent & Trademark Attorney Firms).
Patent Attorney Olivia Murray is attending the CIPA Yorkshire Regional Meeting 2026 in Leeds on 12 March.
Overview of EMA-defined biosimilars, EU IP protections and limits including Bolar exemption, SPC manufacturing waiver, skinny labelling and loss of ex
Partner Gillian Farmer is attending WTR Live: Brand Strategy Summit Europe 2026 on March 4 in London.
The UK Supreme Court has reshaped software patent assessment, moving away from Aerotel toward greater EPO harmonisation and confirming that an ANN is
Two recent invalidity decisions show the risks of relying on online marketplace listings as prior art and demonstrate how design freedom shapes assess
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflect
The UPC Court of Appeal has clarified its inventive step framework. We compare the UPC’s approach with the EPO’s Problem-Solution analysis, highli
An analysis of T-628/24, where the General Court upheld revocation of Lego’s EU design for a modified plate, questioning how informed users and subt
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
The Brooklyn Beckham trade mark raises key questions about who controls a celebrity’s own name, the limits of the “own name” defence and the lon
We reflect on a year of life sciences innovation, highlighting Clarivate’s Drugs to Watch 2025, emerging therapy trends, AI-driven R&D and the evolv
The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential bu
Partners Dr Joanna Peak and Marcus Sims are attending The Pharma & Biotech Patent Litigation Summit Europe on 19-21 January in Amsterdam.
An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they r
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Dr Isabel Blanco in our Spanish trade marks team has been appointed as a Partner of Boult Wade Tennant Spain, S.L.P.
Boult’s trade mark team has been nominated for Trademark Prosecution (Patent & Trademark Attorney Firms).
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Sign up to our insights so you can keep on top of the latest IP developments and updates.
SIGN UP
Dr Isabel Blanco in our Spanish trade marks team has been appointed as a Partner of Boult Wade Tennant Spain, S.L.P.
Boult’s trade mark team has been nominated for Trademark Prosecution (Patent & Trademark Attorney Firms).
From 1 January 2026, the UPC has increased its court fees by around 33%, with an additional 10% increase for Court of Appeal value-based fees, reflecting inflation and operational needs.
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Partner Dr Susi Fish is attending the 2026 IPOwners Spring Summit in Washington, DC on 18 March. The conference is...
Patent Attorney Olivia Murray is attending the CIPA Yorkshire Regional Meeting 2026 on 12 March in Leeds. The event is...
Partner Gillian Farmer is attending WTR Live: Brand Strategy Summit Europe 2026 on 4-5 March. This event unites senior brand...
IPxNW is a leading networking event for professionals passionate about intellectual property across the North West — bringing together patent...
The Pharma & Biotech Patent Litigation Summit is a major European conference for life-sciences intellectual property professionals, focusing on patent...
LSPN Europe 2025 will focus on end-to-end patent lifecycle management, offering practical strategies for protecting and commercialising innovations in life...
The CIPA Life Sciences Conference is the leading UK event for IP professionals in the pharmaceutical, biotechnology and medical device...
APAA Malaysia 2025 will bring together IP professionals from across the Asia-Pacific region for a week of policy discussions, practical...
BIO-Europe 2025 is Europe’s premier annual partnering conference for the biotechnology, pharmaceutical and investment sectors. With over 5,000 attendees from...
The 12th Lsbc Central European Life Science Investment Conference top-level theme is: "The DNA of capital – Cracking the code...
Hosted jointly by the ABA Forum on the Entertainment & Sports Industries and the Section of Intellectual Property Law, this...
Organised by the Pharmaceutical Trademarks Group, this conference will bring together trademark professionals to discuss current challenges and opportunities in...
The Life Sciences Strategy Summit on IP & Exclusivity will convene legal and scientific experts to examine critical issues surrounding...